Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AMLODIPINE\OLMESARTAN: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

45.3%
Female
54.7%
Male

Age Information

The average age of patients reporting adverse events with AMLODIPINE\OLMESARTAN is 64.0 years.

Geographic Distribution

The majority of adverse event reports for AMLODIPINE\OLMESARTAN originate from US.

Report Summary & Outcomes

69
Total Reports
69
As Primary/Secondary Suspect
11
Deaths Reported
35
Hospitalizations
3
Life-Threatening
3
Disabilities

Reporting Timeline

First adverse event report: 20110101. Most recent report: 20250408. View full timeline →

More About AMLODIPINE\OLMESARTAN

AMLODIPINE\OLMESARTAN Full Profile Reports by Year Drug Interactions